Eliem Therapeutics, Inc. (ELYM)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 03:21PM EDT. Market open.
| Previous Close | 9.32 |
| Open | 9.38 |
| Bid | 9.18 x 200 |
| Ask | 9.33 x 100 |
| Day's Range | 9.24 - 10.23 |
| 52 Week Range | 2.34 - 11.55 |
| Volume | |
| Avg. Volume | 878,165 |
| Market Cap | 257M |
| Beta (5Y Monthly) | -0.35 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.30 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireEliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from leading life sciences investors Combined company to focus on clinical development of lead product candidate, TNT119, in upcoming Phase 2 clinical trials in systemic lupus erythematosus and immune thrombocytopenia Co
Simply Wall St.Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
Eliem Therapeutics (NASDAQ:ELYM) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
© 2024 Yahoo. All rights reserved.